Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan

Koga, Tomohiro ; Okada, Akitomo ; Fukuda, Takaaki ; Hidaka, Toshihiko ; Ishii, Tomonori ; Ueki, Yukitaka ; Kodera, Takao ; Nakashima, Munetoshi ; Takahashi, Yuichi ; Honda, Seiyo ; Horai, Yoshiro ; Watanabe, Ryu ; Okuno, Hiroshi ; Aramaki, Toshiyuki ; Izumiyama, Tomomasa ; Takai, Osamu ; Miyashita, Taiichiro ; Sato, Shuntaro ; Kawashiri, Shin-Ya ; Iwamoto, Naoki ; Ichinose, Kunihiro ; Tamai, Mami ; Origuchi, Tomoki ; Nakamura, Hideki ; Aoyagi, Kiyoshi ; Eguchi, Katsumi ; Kawakami, Atsushi Kuwana, Masataka

PloS one, 2017-05, Vol.12 (5), p.e0175281-e0175281 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível